Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01247974 · ClinicalTrials.gov registry record · NA
Evaluation Of New Onset Postoperative Atrial Fibrillation
A NA study, sponsored by Elutia.
- Completed
- Registry status
- NA
- Development phase
- 439
- Enrollment target
NCT01247974 is a NA study that has completed, run by Elutia. The registered enrollment target is 439 participants.
The verdict
NCT01247974, a NA study, has completed, sponsored by Elutia.
- COMPLETED
- Registry status
- NA
- Development phase
- 439 participants
- Enrollment target
Study Summary
This is a multi-center, prospective, randomized and controlled clinical trial comparing the safety and efficacy of the CorMatrix ECM for Pericardial Closure to reduce the incidence of new onset postoperative atrial fibrillation by circumferentially reconstructing the normal pericardial anatomy following isolated, first-time, CABG procedures compared to subjects that do not undergo pericardial closure. This trial will be conducted at up to 20 clinical sites in the U.S.
Interventions
- DEVICE CorMatrix ECM for Pericardial Closure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 439 participants |
| Start Date | 2010-12 |
| Est. Completion | 2012-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01247974
The ClinicalTrials.gov registry entry for NCT01247974 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 439 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Elutia, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CorMatrix ECM for Pericardial Closure is the first listed.
NCT01247974 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01247974 about?
NCT01247974 is a clinical study titled "Evaluation Of New Onset Postoperative Atrial Fibrillation". This is a multi-center, prospective, randomized and controlled clinical trial comparing the safety and efficacy of the CorMatrix ECM for Pericardial Closure to reduce the incidence of new onset postoperative atrial fibrillation by circumferentially reconstructing the normal pericardial anatomy follo...
What is the current status of trial NCT01247974?
This trial is currently completed. It is a NA study. The enrollment target is 439 participants. The study started on 2010-12. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01247974?
The interventions under investigation include: CorMatrix ECM for Pericardial Closure (DEVICE).
Who is sponsoring clinical trial NCT01247974?
This trial is sponsored by Elutia, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.